Expert advocates citizen-focused new health system for Nigeria
Emeritus Professor Oladipo Akinkugbe has called for a new health system that is tailored to the needs of the ordinary man in the street
Why Nigerians defecate publicly
Special report on why improved public awareness is not enough to reduce public defecation in Nigeria
First aid tips to save accident victims
The first few minutes of a medical emergency are always critical, but nearly two thirds of us admit we wouldn’t know what to do
Study identifies risk factors associated with neonatal deaths in Nigeria
A new study has identified risk factors associated with neonatal deaths in Nigeria using the 2008 Nigeria Demographic and Health Survey
Doctors call for Lassa fever treatment centers in south east Nigeria
The South East zonal caucus of Nigeria Medical Association (NMA) has enjoined the Nigerian government to establish health centres and facilities where Lassa fever patients could be treated and managed
Experimental Ebola drug to become more widely available
The World Health Organization (WHO) said it would
convene a meeting of medical ethics experts next week to consider the
implications of making experimental Ebola drugs more widely available.
Handshakes spread more germs than fist bumps, new study reveals
A new study conducted in UK said fist bumps spread far fewer germs than the traditional handshake, and even the high five.
Nigerian doctors call for forensic investigation into Abuja bomb blast
10:15 Abuja, bomb blast, Dr Osahon Enabulele, forensic medicine, forensic science, Nigerian Medical Association, NMA, science, terrorism
No comments
The Nigerian Medical Association (NMA) has called on the government to carry out a forensic investigation into the Abuja bomb blast incident.
AstraZeneca boosts health research in Nigeria with new research grant
07:19 AstraZeneca Nigeria Research Grant, communicable diseases, grants, infection, non-communicable diseases, research, science
1 comment
AstraZeneca
Nigeria Research Grant, an initiative to facilitate research in both
communicable and non-communicable diseases (NCDs), has been launched. The grant
follows closely on the recent successful launch of a similar venture in Kenya
earlier this year.
Nigerian Medical Colleges To Bring Scientific Evidence To Herbal Medicine
13:50 college, cure, healthcare, herbal medicine, medical school, medicine, Nigeria, science
5 comments
Nigeria's health minister, Prof. Onyebuchi Chukwu has announced that medical schools across Nigeria will soon be asked to incorporate herbal medicine into the curricula. Speaking in Abuja, the minister said the move is essential to enhance the standard of Nigeria's health sector.
University of Ibadan Holds Inaugural Lecture On Microbes
11:03 inaugural lecture, microbes, nature, Pharmaceutical Microbiology., Prof. Bolanle A. Adeniyi, science, University of Ibadan
No comments
Nigeria's premier university, the University of Ibadan has announced that its eighth inaugural lecture holding this Thursday 30 May, 2013, will be focusing on microbes.
According to the university, the lecture will be delivered by Prof. Bolanle A. Adeniyi of the department of Pharmaceutical Microbiology.
Prof. Adeniyi would be speaking on the title "Microbes; Culprits And Their Attackers On Natures Field" at the Trenchard Hall, University Of Ibadan by 5pm.
In a statement signed by the registrar of the university, Olujimi Iretola Olukoya MNIM, FPA, the university said the lecture will be chaired by the Vice Chancellor, Prof. Isaac Folorunso Adewole, FAS and is open to the general public.
The lecturer holds a BSc and MSc from the University of Ilorin and a PhD from the University of Ibadan. She is a professor of pharmaceutical microbiology and has published extensively in the field. Some of her published works as highlighted by University of Ibadan's website are listed below.
-
Lajubutu, B.A. (1994). Antibacterial activity of diosquinone isolated from Diospyros tricolor. Planta Medica. Vol. 60: 477-478
-
Lajubutu, B.A., Pinney, R. J., Roberts, M. F., Odelola, H. A. . and Oso, B. A. (1995). Antibacterial activity of diosquinone and plumbagin from the Root of Diospyros mespiliformis (Hostch) [Ebenaceae]. Phytotherapy Research. Vol. 9: 346-350.
-
Adeniyi, B. A., Fong, H.H.S., Pezzuto, J.M. . Luyengi, L. and Odelola, H.A. (2000). Antibacterial activity of diospyrin, isodiospyrin, and bisisodiospyrin from Diospyros piscatorial (Gurke) [Ebenaceae]. Phytotherapy Research .Vol 14 :112-117.http://pharm.ui.edu.ng/sites/default/files/Antibacterial activity of methanolic extract of Garcinia kola_0.pdf">Read Abstract
-
Adeniyi, B. A., Robert, M. F. , Chai, H. and Fong, H.S.S. (2003). In-vitro cytotoxicity of diosquinone, a naphthoquinone epoxide. Phytotherapy Research. Vol. 17: 282-284. Read Abstract
-
Adeniyi, B. A., Grooves, M. J. and Gangadharam, P. R. J. (2004). In-vitro anti-mycobacterial activities of three species of Cola plant extracts (Sterculiaceae). Phytotherapy Research (18): 414-418.
-
Adeniyi,B. A. and Anyiam, F. M. (2004). In-vitro Anti-Helicobacter pylori potential of methanol extract of Allium ascalonicum Linn. (Liliaceae) leaf: Susceptibility and effect on urease activity. Phythotherapy Research. Vol. 18: 358-361.Read Abstract
-
Mahady, G. B., Bhamarapravati, S., Adeniyi, B. A., Doyle, B. J., Locklear, T. D. Slover C. and Pendland, S. L. (2006). Traditional Thai medicines inhibit Helicobacter pylori in-vitro and in-vivo: support for ethno medical use. Ethnobotany Research and Applications (4): 159-165.
-
Soge, O.O. Adeniyi, B. A. and Roberts, M. C. (2006). New antibiotic resistance genes associated with CTX-M plasmids from uropathogenic Nigerian Klebsiella pneumoniae. Journal of Antimicrobial Chemotherapy (58): 1048-1053.
-
Adeniyi, B. A., Lawal, T. O.,and Mahady, G. B. (2009). In vitro susceptibility of Helicobacter pylori to extracts of Eucalyptus camaldulensis and Eucalyptus torelliana.Pharmaceutical Biology 47(1):99–102
-
Gaus,K., Huang,Y., Israel, D. A., Pendland, S. L., Adeniyi, B. A., and Mahady, G. B. (2009). Standardized ginger (Zingiber officinale) extract reduces bacterial load and suppresses acute and chronic inflammation in Mongolian gerbils infected with cagA+ Helicobacter pylori. Pharmaceutical Biology ; 47(1): 92-98.
-
Ayeni, F. A., Adeniyi, B. A., Ogunbanwo, S. T, Tabasco, R., Paarup T., Peláez C., Requena T. (2009). Inhibition of uropathogens by lactic acid bacteria isolated from dairy foods and cow's intestine in western Nigeria. Archives of Microbiology. Vol. 191:639-648.
-
Lawal, T. O., Adeniyi, B. A., Wan, B. Franzblau, S. G. and Mahady, G.B. (2010). In-vitro susceptibility of Mycobacterium tuberculosis H37Rv to extracts of Uvaria afzelli Scott Elliot and Tetracera alnifolia Willd. African Journal of Biomedical Research. Accepted
-
Ayeni, F. A., Adeniyi, B. A., Ogunbanwo, S. T., Nader-Macias M. E. and Ruas-Madiedo, P. (2011). Survival of Weissella confusa and Lactobacillus paracasei strains in fermented milks under cold storage and after freeze-drying. Milk Science 66 (1) 61-64.
n-3 Fatty Acids Have No Effect On Cardiovascular Diseases, New Study Shows
14:15 cardiovascular disease, heart, heart failure, heart research, hypertension, n-3 fattty acids, New England Journal of Medicine, omega-3 fatty acids, science, The Risk and Prevention Study Collaborative Group
No comments
A major setback has hit cardiovascular disease treatment and management with the discovery that n-3 polyunsaturated fatty acids have no beneficial effect on individuals who have history of myocardial infarction or heart failure.
In the study published in the New England Journal of Medicine, The Risk and Prevention Study Collaborative Group concluded that daily treatment with n-3 fatty acids has no effect on the outcomes of cardiovascular diseases.
"In a large general-practice cohort of patients with multiple
cardiovascular risk factors, daily treatment with n−3 fatty acids did
not reduce cardiovascular mortality and morbidity," the researchers stated.
In the Società Prodotti Antibiotici-funded research conducted in Italy, researchers recruited 12,513 participants out of which 6244 were randomly assigned to n−3 fatty acids and 6269 to placebo.
" With a median of 5 years of follow-up, the primary end point occurred
in 1478 of 12,505 patients included in the analysis (11.8%), of whom 733
of 6239 (11.7%) had received n−3 fatty acids and 745 of 6266 (11.9%)
had received placebo (adjusted hazard ratio with n−3 fatty acids, 0.97;
95% confidence interval, 0.88 to 1.08; P=0.58). The same null results
were observed for all the secondary end points," they said in the paper.
Prior to this study, n-3 fatty acids such as omega-3 fatty acids were believed to have health benefits in the prevention and treatment of cardiovascular diseases. In Nigeria, several adverts are aired claiming that products containing n-3 fatty acids are heart-friendly. But with this, it is expected that relevant bodies including the National Agency for Food and Drug Administration and Control (NAFDAC) and Consumer Protection Council (CPC) will ensure that adverts aired in Nigeria reflect this study report that n-3 fatty acids don't have any effect on cardiovascular diseases.
HealthNewsNG has cotacted NAFDAC and CPC for comments.






